Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABCL
ACAD
Add up to 3 more stocks
ABCL
AbCellera Biologics Inc.
-0.87%
$13.66-0.12Delayed quote: Oct 6, 2026, 11:45 AM EDT
Market Cap
$4.17B
52W Range
$2.75 - $15.02
ACAD
Acadia Pharmaceuticals Inc.
-0.10%
$20.09-0.02Delayed quote: Oct 6, 2026, 11:45 AM EDT
Market Cap
$3.44B
52W Range
$19.57 - $30.96
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 9.05 |
| Forward P/E | N/A | 32.62 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 4.66 | 2.63 |
| P/S Ratio | 63.04 | 3.02 |
| P/FCF Ratio | N/A | 19.73 |
| EV/EBITDA | N/A | 31.80 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 61.6% | 91.1% |
| Operating Margin | -289.0% | 7.6% |
| Net Margin | -248.8% | 33.4% |
| ROE | -18.4% | 29.1% |
| ROA | -12.6% | 21.8% |
| ROIC | -17.9% | 6.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 12.77 | 3.39 |
| Quick Ratio | 12.63 | 3.30 |
| Debt/Equity | 0.15 | 0.06 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.